ImmunityBio , a commercial-stage immunotherapy company, today announced that the European Commission has granted conditional marketing authorization for ANKTIVA® (nogapendekin alfa inbakicept) in ...
On 8 September 2025 CoinShares International Limited ('CoinShares”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF) announced a joint merger plan with Vine Hill Capital Investment Corp (Nasdaq: VCIC) ('Vine ...
22h
Odysseus Holdings Limited: CoinShares publishes the Scheme Circular in relation to joint merger plan
February 2026 | SAINT HELIER, Jersey | On 8 September 2025 CoinShares International Limited ("CoinShares") (Nasdaq Stockholm: CS; US OTCQX: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results